Demographic and baseline characteristics of safety population participants and sexual partners.
| Participant . | |||||
|---|---|---|---|---|---|
| . | Sildenafil (n = 99) . | Placebo (n = 134) . | P value . | ||
| . | Mean . | SD . | Mean . | SD . | . |
| Age, y | 36.3 | 7.14 | 36.3 | 7.21 | .89 |
| Baseline BMI, kg/m2 | 27.1 | 4.7 | 27.2 | 4.6 | .95 |
| n | % Total product group | n | % Total product group | ||
| Cisgender female | 99 | 100 | 134 | 100 | NA |
| Ethnicity | |||||
| Hispanic or Latino | 14 | 14.1 | 24 | 17.9 | .44 |
| Not Hispanic or Latino | 85 | 85.9 | 110 | 82.1 | |
| Race | |||||
| American Indian or Alaskan Native | 0 | 0 | 2 | 1.5 | .37 |
| Asian | 5 | 5.1 | 7 | 5.2 | |
| Black or African American | 6 | 6.1 | 14 | 10.4 | |
| Native Hawaiian or Other Pacific Islander | 1 | 1.0 | 0 | 0 | |
| White | 84 | 84.8 | 110 | 82.1 | |
| Mixed race or other | 3 | 3.0 | 1 | 0.7 | |
| Employment status | |||||
| Employed | 84 | 84.8 | 108 | 80.6 | .40 |
| Not employed | 15 | 15.2 | 26 | 19.4 | |
| Highest level of education | |||||
| High school | 5 | 5.1 | 10 | 7.5 | .74 |
| College or postgraduate | 94 | 94.9 | 123 | 91.8 | |
| Missing or did not report | 0 | 0 | 1 | 1.0 | |
| Partner | |||||
| Sildenafil (n = 91) | Placebo (n = 112) | P value | |||
| Mean | SD | Mean | SD | ||
| Age, y | 38.5 | 8.60 | 37.6 | 8.48 | .64 |
| BMI, kg/m2 | 28.5 | 5.7 | 28.7 | 4.5 | .92 |
| n | % Total product group | N | % Total product group | ||
| Sex | |||||
| Female | 5 | 5.5 | 10 | 8.9 | .35 |
| Male | 86 | 94.5 | 102 | 91.1 | |
| Participant . | |||||
|---|---|---|---|---|---|
| . | Sildenafil (n = 99) . | Placebo (n = 134) . | P value . | ||
| . | Mean . | SD . | Mean . | SD . | . |
| Age, y | 36.3 | 7.14 | 36.3 | 7.21 | .89 |
| Baseline BMI, kg/m2 | 27.1 | 4.7 | 27.2 | 4.6 | .95 |
| n | % Total product group | n | % Total product group | ||
| Cisgender female | 99 | 100 | 134 | 100 | NA |
| Ethnicity | |||||
| Hispanic or Latino | 14 | 14.1 | 24 | 17.9 | .44 |
| Not Hispanic or Latino | 85 | 85.9 | 110 | 82.1 | |
| Race | |||||
| American Indian or Alaskan Native | 0 | 0 | 2 | 1.5 | .37 |
| Asian | 5 | 5.1 | 7 | 5.2 | |
| Black or African American | 6 | 6.1 | 14 | 10.4 | |
| Native Hawaiian or Other Pacific Islander | 1 | 1.0 | 0 | 0 | |
| White | 84 | 84.8 | 110 | 82.1 | |
| Mixed race or other | 3 | 3.0 | 1 | 0.7 | |
| Employment status | |||||
| Employed | 84 | 84.8 | 108 | 80.6 | .40 |
| Not employed | 15 | 15.2 | 26 | 19.4 | |
| Highest level of education | |||||
| High school | 5 | 5.1 | 10 | 7.5 | .74 |
| College or postgraduate | 94 | 94.9 | 123 | 91.8 | |
| Missing or did not report | 0 | 0 | 1 | 1.0 | |
| Partner | |||||
| Sildenafil (n = 91) | Placebo (n = 112) | P value | |||
| Mean | SD | Mean | SD | ||
| Age, y | 38.5 | 8.60 | 37.6 | 8.48 | .64 |
| BMI, kg/m2 | 28.5 | 5.7 | 28.7 | 4.5 | .92 |
| n | % Total product group | N | % Total product group | ||
| Sex | |||||
| Female | 5 | 5.5 | 10 | 8.9 | .35 |
| Male | 86 | 94.5 | 102 | 91.1 | |
Demographic and baseline characteristics of safety population participants and sexual partners.
| Participant . | |||||
|---|---|---|---|---|---|
| . | Sildenafil (n = 99) . | Placebo (n = 134) . | P value . | ||
| . | Mean . | SD . | Mean . | SD . | . |
| Age, y | 36.3 | 7.14 | 36.3 | 7.21 | .89 |
| Baseline BMI, kg/m2 | 27.1 | 4.7 | 27.2 | 4.6 | .95 |
| n | % Total product group | n | % Total product group | ||
| Cisgender female | 99 | 100 | 134 | 100 | NA |
| Ethnicity | |||||
| Hispanic or Latino | 14 | 14.1 | 24 | 17.9 | .44 |
| Not Hispanic or Latino | 85 | 85.9 | 110 | 82.1 | |
| Race | |||||
| American Indian or Alaskan Native | 0 | 0 | 2 | 1.5 | .37 |
| Asian | 5 | 5.1 | 7 | 5.2 | |
| Black or African American | 6 | 6.1 | 14 | 10.4 | |
| Native Hawaiian or Other Pacific Islander | 1 | 1.0 | 0 | 0 | |
| White | 84 | 84.8 | 110 | 82.1 | |
| Mixed race or other | 3 | 3.0 | 1 | 0.7 | |
| Employment status | |||||
| Employed | 84 | 84.8 | 108 | 80.6 | .40 |
| Not employed | 15 | 15.2 | 26 | 19.4 | |
| Highest level of education | |||||
| High school | 5 | 5.1 | 10 | 7.5 | .74 |
| College or postgraduate | 94 | 94.9 | 123 | 91.8 | |
| Missing or did not report | 0 | 0 | 1 | 1.0 | |
| Partner | |||||
| Sildenafil (n = 91) | Placebo (n = 112) | P value | |||
| Mean | SD | Mean | SD | ||
| Age, y | 38.5 | 8.60 | 37.6 | 8.48 | .64 |
| BMI, kg/m2 | 28.5 | 5.7 | 28.7 | 4.5 | .92 |
| n | % Total product group | N | % Total product group | ||
| Sex | |||||
| Female | 5 | 5.5 | 10 | 8.9 | .35 |
| Male | 86 | 94.5 | 102 | 91.1 | |
| Participant . | |||||
|---|---|---|---|---|---|
| . | Sildenafil (n = 99) . | Placebo (n = 134) . | P value . | ||
| . | Mean . | SD . | Mean . | SD . | . |
| Age, y | 36.3 | 7.14 | 36.3 | 7.21 | .89 |
| Baseline BMI, kg/m2 | 27.1 | 4.7 | 27.2 | 4.6 | .95 |
| n | % Total product group | n | % Total product group | ||
| Cisgender female | 99 | 100 | 134 | 100 | NA |
| Ethnicity | |||||
| Hispanic or Latino | 14 | 14.1 | 24 | 17.9 | .44 |
| Not Hispanic or Latino | 85 | 85.9 | 110 | 82.1 | |
| Race | |||||
| American Indian or Alaskan Native | 0 | 0 | 2 | 1.5 | .37 |
| Asian | 5 | 5.1 | 7 | 5.2 | |
| Black or African American | 6 | 6.1 | 14 | 10.4 | |
| Native Hawaiian or Other Pacific Islander | 1 | 1.0 | 0 | 0 | |
| White | 84 | 84.8 | 110 | 82.1 | |
| Mixed race or other | 3 | 3.0 | 1 | 0.7 | |
| Employment status | |||||
| Employed | 84 | 84.8 | 108 | 80.6 | .40 |
| Not employed | 15 | 15.2 | 26 | 19.4 | |
| Highest level of education | |||||
| High school | 5 | 5.1 | 10 | 7.5 | .74 |
| College or postgraduate | 94 | 94.9 | 123 | 91.8 | |
| Missing or did not report | 0 | 0 | 1 | 1.0 | |
| Partner | |||||
| Sildenafil (n = 91) | Placebo (n = 112) | P value | |||
| Mean | SD | Mean | SD | ||
| Age, y | 38.5 | 8.60 | 37.6 | 8.48 | .64 |
| BMI, kg/m2 | 28.5 | 5.7 | 28.7 | 4.5 | .92 |
| n | % Total product group | N | % Total product group | ||
| Sex | |||||
| Female | 5 | 5.5 | 10 | 8.9 | .35 |
| Male | 86 | 94.5 | 102 | 91.1 | |
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
